Incyclix Bio

A next-generation cell cycle control company advancing precision treatments for cancer

placeDurham, North Carolina, United States calendar_todayFounded 2020 groups6 employees language incyclixbio.com

Social engagement

Social engagement: 1.7K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

7 investors on record; lead investors include Boxer Capital.

Investor typeCountShare
Venture capital343%
Private equity114%
Other / undisclosed343%
Coming soon